Publications by authors named "Melissa Larson"

Claim this Profile
F
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.
Matthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly, Christopher R Flowers, Diego Villa, Melissa C Larson

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of Rituximab Maintenance After First-line Bendamustine-Rituximab in Patients with Mantle Cell Lymphoma.
Yucai Wang, Melissa C Larson, Steven R Hwang, Diego Villa, Laveniya Kugathasan

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence and predictors of patient reported fertility discussions in non-Hodgkin lymphoma patients: utilizing the lymphoma epidemiology of outcomes (LEO) cohort study.
Nadia Toumeh, Melissa Larson, Brianna Negaard, Carla Casulo, Sairah Ahmed

Leuk Lymphoma· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancer.
Gottfried E Konecny, Tara M Davidson, Coriolan L Lebreton, Leah A Marsh, Deandra K Chetram, Melissa C Larson

Int J Gynecol Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing drivers of disparate outcomes and applicability of risk stratification in a cohort of patients with myelofibrosis.
Andrew Palmer, Garth Rauscher, Alexa Schoen, Madelyn Burkart, Ashley Dunton, Melissa L Larson

Blood Cancer J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Modernizing Eligibility Criteria on Enrollment and Representation in Acute Myeloid Leukemia Clinical Trials.
Andrew Hantel, Yating Wang, Angel Cronin, Irum Khan, Ivy Elizabeth Abraham, Melissa L Larson

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitotic MTH1 inhibitor karonudib kills epithelial ovarian cancer independent of platinum sensitivity.
Rachel M Hurley, Jill M Wagner, Arun Kanakkanthara, Annapoorna Venkatachalam, Aaron M Deisinger, Melissa C Larson

Exp Hematol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by the Cell of Origin.
Geffen Kleinstern, Dennis P Robinson, Lisa M Rimsza, Melissa C Larson, Rebecca L King

Cancer Epidemiol Biomarkers Prev· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of rucaparib plus PLX038A in serous endometrial carcinoma.
Xiaonan Hou, Valentina Zanfagnin, Conway Xu, Erik Jessen, Yuanhang Liu, Melissa C Larson

J Exp Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study.
Samuel Yamshon, Jean L Koff, Melissa C Larson, Brad S Kahl, Carla Casulo

Am J Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma.
Loretta J Nastoupil, Clark R Andersen, Amy Ayers, Yucai Wang, Thomas M Habermann, Melissa A Larson

Clin Lymphoma Myeloma Leuk· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of lymphoid malignancy associated with cancer predisposition genes.
Nicholas J Boddicker, Raphael Mwangi, Dennis P Robinson, Cristine Allmer, Allison C Rosenthal, Melissa C Larson

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium.
Jonathan R Day, Melissa C Larson, Urshila Durani, Jean L Koff, Yucai Wang

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX models.
Manisha Taya, Xiaonan Hou, Jennifer T Veneris, Nina Kazi, Melissa C Larson

J Gynecol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature.
Côme Bommier, Brian K Link, Brianna J Gysbers, Matthew J Maurer, Melissa C Larson

Blood Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis.
Brooj Abro, Matthew J Maurer, Thomas M Habermann, W Richard Burack, Jennifer R Chapman, Melissa C Larson

Blood· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proapoptotic activity of JNK-sensitive BH3-only proteins underpins ovarian cancer response to replication checkpoint inhibitors.
Annapoorna Venkatachalam, Cristina Correia, Kevin L Peterson, Xianon Hou, Paula A Schneider, Melissa C Larson

Mol Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia.
Andrew Palmer, Garth Rauscher, Ivy Abraham, Madelyn Burkart, Ami Dave, Melissa L Larson

Blood Adv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma.
Matthew J Maurer, Carla Casulo, Melissa C Larson, Thomas M Habermann, Izidore S Lossos

Haematologica· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.
Eileen O Dareng, Simon G Coetzee, Jonathan P Tyrer, Pei-Chen Peng, Will Rosenow, Melissa C Larson

Am J Hum Genet· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
James R Cerhan, Matthew J Maurer, Brian K Link, Andrew L Feldman, Thomas M Habermann, Melissa C Larson

Am J Hematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments.
Jordan E Krull, Kerstin Wenzl, Melissa A Hopper, Michelle K Manske, Vivekananda Sarangi, Melissa C Larson

Cell Rep Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.
Allison M Bock, Jennifer J Gile, Melissa C Larson, Kittika Poonsombudlert, Reema K Tawfiq

Blood Cancer J· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas.
Melissa A Hopper, Kerstin Wenzl, Keenan T Hartert, Jordan E Krull, Abigail R Dropik, Melissa C Larson

Hematol Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generating Mitochondrial-Nuclear Exchange (MNX) Mice to Identify Mitochondrial Determinants of Cancer Metastasis.
Danny R Welch, Melissa A Larson, Carolyn J Vivian, Jay L Vivian

Methods Mol Biol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis